Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT
Standard
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT. / Gran, Charlotte; Wang, Junfeng; Nahi, Hareth; Koster, Linda; Gahrton, Gösta; Einsele, Herman; Niittyvoupio, Riitta; Edinger, Matthias; Beelen, Dietrich; Ciceri, Fabio; Bornhäuser, Martin; Finke, Jürgen; de Wreede, Liesbeth C; Ljungman, Per; Mielke, Stephan; Tischer, Johanna; Garderet, Laurent; Schönland, Stefan; Yakoub-Agha, Ibrahim; Kröger, Nicolaus.
in: BRIT J HAEMATOL, Jahrgang 189, Nr. 5, 06.2020, S. e213-e217.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT
AU - Gran, Charlotte
AU - Wang, Junfeng
AU - Nahi, Hareth
AU - Koster, Linda
AU - Gahrton, Gösta
AU - Einsele, Herman
AU - Niittyvoupio, Riitta
AU - Edinger, Matthias
AU - Beelen, Dietrich
AU - Ciceri, Fabio
AU - Bornhäuser, Martin
AU - Finke, Jürgen
AU - de Wreede, Liesbeth C
AU - Ljungman, Per
AU - Mielke, Stephan
AU - Tischer, Johanna
AU - Garderet, Laurent
AU - Schönland, Stefan
AU - Yakoub-Agha, Ibrahim
AU - Kröger, Nicolaus
PY - 2020/6
Y1 - 2020/6
KW - Adolescent
KW - Adult
KW - Aged
KW - Busulfan/administration & dosage
KW - Disease-Free Survival
KW - Drug Evaluation
KW - Female
KW - Hematopoietic Stem Cell Transplantation
KW - Humans
KW - Kaplan-Meier Estimate
KW - Male
KW - Middle Aged
KW - Multiple Myeloma/drug therapy
KW - Myeloablative Agonists/administration & dosage
KW - Proportional Hazards Models
KW - Retrospective Studies
KW - Transplantation Conditioning/methods
KW - Transplantation, Autologous
KW - Transplantation, Homologous
KW - Treatment Outcome
KW - Young Adult
U2 - 10.1111/bjh.16642
DO - 10.1111/bjh.16642
M3 - SCORING: Journal article
C2 - 32301111
VL - 189
SP - e213-e217
JO - BRIT J HAEMATOL
JF - BRIT J HAEMATOL
SN - 0007-1048
IS - 5
ER -